Ehrlich Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305K Buy
264
+28
+12% +$33K 0.16% 96
2026
Q2
$283K Buy
236
+5
+2% +$5.11K 0.15% 97
2026
Q1
$212K Sell
231
-8
-3% -$8.11K 0.12% 110
2025
Q4
$257K Buy
+239
New +$229K 0.15% 95
2025
Q2
– Sell
-245
Closed -$202K – 116
2025
Q1
$202K Buy
+245
New +$204K 0.15% 99
2024
Q4
– Sell
-245
Closed -$217K – 116
2024
Q3
$217K Buy
245
+9
+4% +$8.09K 0.15% 103
2024
Q2
$214K Sell
236
-40
-14% -$32K 0.17% 98
2024
Q1
$215K Buy
+276
New +$196K 0.18% 93

Other funds holding LLY

Ehrlich Financial Group's LLY Position: Q3 2026 in Review

Ehrlich Financial Group increased its Eli Lilly (LLY) stake by 12% in Q3 2026, buying an estimated $33K and bringing the position to 264 shares worth $305K. The position accounts for 0.16% of the portfolio, ranked #96.

Ehrlich Financial Group first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ehrlich Financial Group held 264 shares of Eli Lilly worth $305K as of Q3 2026.
  • Ehrlich Financial Group bought 28 Eli Lilly shares in Q3 2026, an estimated $33K.
  • Eli Lilly made up 0.16% of Ehrlich Financial Group's portfolio in Q3 2026, its #96 holding.
  • Ehrlich Financial Group first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ehrlich Financial Group's 13F filing for Q3 2026, filed 20 Oct 2026.